Open to opportunities

Mo'men Salem

@momensalem

Message

Medicinal chemist specializing in design and synthesis of biologically active small molecules.

Egypt

Message

What I'm looking for

I seek research-focused roles where I can lead medicinal chemistry projects, mentor students, collaborate across disciplines, and translate synthetic discoveries into therapeutic candidates.

I am a medicinal chemist and lecturer with a strong track record in designing, synthesizing and characterizing biologically active small molecules, and advancing structure–activity relationships to optimize pharmacokinetic properties.

I hold a PhD in Medicinal Chemistry & Drug Design and have supervised interns, MSc and PhD students while teaching undergraduate pharmacy courses; my research produced multiple peer-reviewed publications and conference recognition.

I combine hands-on synthetic expertise, molecular modeling and team leadership with a commitment to rigorous methodology and translational research aimed at anticancer and neurodegenerative disease targets.

Experience

Work history, roles, and key accomplishments

Current

Lecturer in Medicinal Chemistry

Current

Sinai University

Jul 2022 - Present (3 years 2 months)

Designs and synthesizes biologically active small-molecule drugs, optimizes pharmacokinetic properties and structure–activity relationships, and teaches and supervises undergraduates, interns, MSc and PhD students in the Medicinal Chemistry & Drug Design department.

Medicinal Chemistry Drug Design Purification Student supervision

Education

Degrees, certifications, and relevant coursework

Al-Azhar University

Doctor of Philosophy, Medicinal Chemistry & Drug Design

2019 - 2022

PhD in Medicinal Chemistry & Drug Design; thesis on design, synthesis and molecular modeling of new heterocyclic compounds for biological study under Prof. Helmy M. Sakr and Prof. Rezk Ayyad.

Suez Canal University

Master of Science, Pharmaceutical Chemistry

2012 - 2018

Master of Science in Pharmaceutical Chemistry; thesis on design and synthesis of novel N-containing heterocyclic compounds as potential BACE inhibitors for Alzheimer’s disease.